Want to see GB:CIZ full AI Analyst Report?
Cizzle Biotechnology Holdings PLC (CIZ) Ratios
Cizzle Biotechnology Holdings PLC Ratios
GB:CIZ's free cash flow for Q2 2026 was $-367.00K. For the 2026 fiscal year, GB:CIZ's free cash flow was increased by $0.00 and operating cash flow was $-367.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.42 | 1.20 | 9.10 | 4.86 | 4.38 |
| Quick Ratio | 0.42 | 1.20 | 17.43 | 4.86 | 4.38 |
| Cash Ratio | 0.20 | 0.89 | 0.77 | 3.30 | 4.01 |
| Solvency Ratio | -1.18 | -0.00 | -0.00 | -6.27 | -17.98 |
| Operating Cash Flow Ratio | -0.85 | -0.87 | -3.44 | -6.01 | -4.63 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -342.00K | $ 82.00K | $ 1.51M | $ 560.00K | $ 737.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.72 | 6.00 | 1.12 | 1.05 | 1.23 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.15 | 0.42 | 0.00 | 0.50 | 0.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 92.01% | 0.10% | 0.10% | 94.50% | 99.04% |
| EBT Per EBIT | 99.73% | 249.09% | 180.64% | 100.00% | 465.10% |
| Return on Assets (ROA) | -282.04% | -0.44% | -0.10% | -32.68% | -339.39% |
| Return on Equity (ROE) | 203.24% | -2.64% | -0.11% | -34.47% | -418.36% |
| Return on Capital Employed (ROCE) | 221.47% | -1070.73% | -64.76% | -36.48% | -90.82% |
| Return on Invested Capital (ROIC) | 203.78% | -1060.45% | -63.07% | -34.55% | -89.97% |
| Return on Tangible Assets | -282.04% | -0.44% | -0.10% | -129.08% | -410.47% |
| Earnings Yield | -11.25% | -0.04% | -24.74% | -21542.85% | -81402.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -248.00 | 0.00 | 0.00 | 0.00 | -5.04 |
| Capital Expenditure Coverage Ratio | -248.00 | 0.00 | 0.00 | 0.00 | -5.04 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -8.11% | -5.96% | -9206.70% | -20643.26% | -25105.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.12 | -2772.78 | -4041.52 | -4.64 | -1.23 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -18.07 | 73.24 | 4.60 | 1.60 | 5.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.34 | -16.78 | -10.86 | -4.84 | -3.98 |
| Price-to-Operating Cash Flow Ratio | -12.39 | -16.78 | -10.86 | -4.84 | -4.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | -231.07 | 40.42 | 0.05 | -0.01 |
| Enterprise Value Multiple | -8.01 | -6.42 | 0.00 | -3.89 | -1.00 |
| Enterprise Value | 6.03M | 5.64M | -137.06K | -473.77K | -870.18K |
| EV to EBITDA | -8.01 | -6.42 | 0.00 | 0.49 | 0.22 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -12.10 | -15.76 | 0.21 | 0.54 | 0.72 |
| EV to Operating Cash Flow | -12.15 | -15.76 | 0.21 | 0.54 | 0.86 |
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | -0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.01 | 0.03 | 0.05 | 0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 |
| Tax Burden | 0.92 | 0.00 | 0.00 | 0.94 | 0.99 |
| Interest Burden | 1.00 | 2496.58 | 1806.35 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 0.16 | 0.36 | 0.91 | 0.25 |
Currency in GBP
